Topic

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

Drug shortages across Europe are being exacerbated by increased demand, struggling supply chains, and manufacturer suspensions.

Falling Short

Novo Nordisk’s obesity treatment has been so successful the company is now top of the ‘value pile’ in Europe.

Losing Weight, Gaining Value

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

If the Alliance for mRNA Medicines (AMM) tested the waters in June 2023 at the BIO Conference in Boston, then they engaged in a full-fledged triathlon in September, in the heat and humidity of Washington, DC.

Washington, DC Houses mRNA Leadership

European vaccine manufacturing is being boosted with high level investments.  

Booster Shot for Pharma

There are many promising trials in the pipeline that may bring big news for major therapeutic areas.

Clinical Trials and their Impact on the Pharma Industry

Only a significant joint effort across the supply chain will help to make healthcare more sustainable and reduce the impact of climate change on global health.  

A Healthier Tomorrow?

mRNA may be a modality whose chief advances are yet to come.

New Magic from mRNA

The UK and EU have negotiated a new draft deal for Britain to re-join the Horizon Europe research programme.

New Deal on the Horizon

If we view a change opposite of one’s interest as antithetical to innovation, we risk losing sight of our ultimate goal.

Innovation Idolatry

Despite being a relatively small nation, Switzerland is booming for biotech innovation.

From the Editor